Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer’s disease
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Cognitive decline is a cardinal feature of Alzheimer's disease (AD) predominantly linked to synaptic failure, disrupted network connectivity and neurodegeneration. A large body of evidence associates the Wnt pathway with synaptic modulation and cognitive processes, suggesting a potential role for aberrant Wnt signaling in cognitive impairment. In fact, altered expression of key Wnt pathway components has been found in brains of AD patients as well as AD animal models supporting a deregulated pathway in AD. The evidence for deregulated Wnt signaling in AD, however, remains sparse and focused on isolated Wnt pathway components. Here, we provide the first comprehensive pathway-focused evaluation of the Wnt pathway in the entorhinal cortex and hippocampus of AD brains. Our data demonstrate altered Wnt pathway gene expression at all levels of the pathway in both medial temporal lobe regions with the hippocampus exhibiting most pronounced changes. Furthermore, the Wnt pathway constituents Wnt7b and Tcf7l1/Tcf3 showed overlapping gene expression alterations across both medial temporal lobe structures, while β-catenin was inversely expressed between brain regions. We also identified total protein alterations of the intracellular Wnt pathway signaling components β-catenin, Gsk3β and Tcf7l1/Tcf3 and the phosphorylation state of β-catenin and Gsk3β in the hippocampus suggestive of a link between AD and aberrant canonical activity. Alterations in Gsk3β co-appeared with hippocampal kinase-targeted hyperphosphorylation at specific tau epitope in soluble pretangles and prominent tau aggregation exclusively in insoluble neurofibrillary tangles of AD subjects. The Wnt pathway-focused approach confirms altered Wnt signaling in the neurodegenerative AD brain and highlights the potential role of the pathway as a therapeutic target for the treatment of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Shh pathway displays upregulation of its components, Shh, SMO, GLI1, and GLI2, in the hippocampus of human and mouse AD models, whereas PTCH, GLI3, and Wnt signaling components are downregulated [111,112].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [112]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Pfaffl, M. W., Tichopad, A., Prgomet, C., & Neuvians, T. P. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000019559.84305.47 · Cited by 5,065
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 1×
“Functional imaging studies have furthermore demonstrated a breakdown in the connectivity between MTL structures and the rest of the brain in AD highlighting the hippocampus and entorhinal cortex in cognitive impairment (Allen et al. 2007; Greicius et al. 2004).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Silver, N., Best, S., Jiang, J., & Thein, S. L. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-33 · Cited by 1,722
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Wnt signalling regulates adult hippocampal neurogenesis
Lie, D.-C., Colamarino, S. A., Song, H.-J., Désiré, L., Mira, H., Consiglio, A., Lein, E. S., Jessberger, S., Lansford, H., Dearie, A. R., et al. (2005) · Nature · doi:10.1038/nature04108 · Cited by 1,518
The GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 2×
“Conversely, deficits in cognitive abilities have been linked to synaptic loss underscoring that AD is a synaptic disorder affecting neuronal connectivity (DeKosky and Scheff 1990; Scheff et al. 2006).”
BackgroundLucas, J. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 900
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 1×
“1991) and had Braak stages of 4–6 (Braak et al. 1993), while controls had no history of cognitive impairment or neurological/psychiatric disorder.”
BackgroundWNTS in the vertebrate nervous system: from patterning to neuronal connectivity
Ciani, L., & Salinas, P. C. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1665 · Cited by 543
Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
Zhang, Z., Hartmann, H., Minh Do, V., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., et al. (1998) · Nature · doi:10.1038/27208 · Cited by 517
Leroy, K., Yilmaz, Z., & Brion, J. ‐. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00795.x · Cited by 404
Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A. J., Caruso, A., Storto, M., Gaviraghi, G., Terstappen, G. C., & Nicoletti, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1381-04.2004 · Cited by 398
Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease Brain
PEI, J.-J., TANAKA, T., TUNG, Y.-C., BRAAK, E., IQBAL, K., & GRUNDKE-IQBAL, I. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199701000-00007 · Cited by 371
Synaptic and neuritic alterations during the progression of Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370 · cited 1×
“torhinal cortex and hippocampus are recognized as early sites of atrophy with concomitant loss of synaptic contact sites in AD (Braak and Braak 1991; Masliah et al. 1994; Scheff et al. 2006).”
BackgroundSelkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 363
Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R., & Anderton, B. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741587.x · Cited by 362
Reduced Hippocampal Functional Connectivity in Alzheimer Disease
Allen, G., Barnard, H., McColl, R., Hester, A. L., Fields, J. A., Weiner, M. F., Ringe, W. K., Lipton, A. M., Brooker, M., McDonald, E., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1482 · Cited by 355
Murase, S., Mosser, E., & Schuman, E. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00764-x · Cited by 341
Wnt signaling in the nervous system and in Alzheimer's disease
Inestrosa, N. C., & Varela-Nallar, L. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt051 · Cited by 324 · cited 2×
“Additionally, deregulated Wnt signaling has been reported in AD pathology (De Ferrari and Inestrosa 2000; Inestrosa and Varela-Nallar 2014), associating aberrant pathway signaling with neurodegenerative processes.”
BackgroundActivity-dependent synaptic Wnt release regulates hippocampal long term potentiation
Chen, J., Park, C. S., & Tang, S.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511920200 · Cited by 298 · cited 1×
“Recent studies have furthermore proposed an important role for the Wnt pathway in the adult hippocampus involved in neurogenesis and synaptic plasticity (Cerpa et al. 2011; Chen et al. 2006; Lie et al. 2005; Varela-Nallar et al. 2010), indicating a role of Wnt signaling also on sustained network connectivity, memory f…”
BackgroundLoss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline
Seib, D. R. M., Corsini, N. S., Ellwanger, K., Plaas, C., Mateos, A., Pitzer, C., Niehrs, C., Celikel, T., & Martin-Villalba, A. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.010 · Cited by 293
Wnt signaling function in Alzheimer’s disease
De Ferrari and, G. V., & Inestrosa, N. C. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00021-7 · Cited by 289
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., Hall, A., Brickley, S., & Salinas, P. C. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511054 · Cited by 234
Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
Sperbera, B. R., Leight, S., Goedert, M., & Lee, V. M.-Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11902-9 · Cited by 204 · cited 1×
“Here, we characterized the tau phosphorylation pattern of known Gsk3b substrates (Reynolds et al. 2000; Sperber et al. 1995) in soluble and insoluble fractions of the hippocampus present with early tau pathology.”
BackgroundVarela-Nallar, L., Alfaro, I. E., Serrano, F. G., Parodi, J., & Inestrosa, N. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010011107 · Cited by 197
Ferrer, I., Barrachina, M., & Puig, B. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0587-8 · Cited by 196
Gogolla, N., Galimberti, I., Deguchi, Y., & Caroni, P. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.022 · Cited by 180
GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration
Salcedo-Tello, P., Ortiz-Matamoros, A., & Arias, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189728 · Cited by 166
Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain
. Swatton, J. E., Sellers, L. A., Faull, R. L. M., Holland, A., Iritani, S., & Bahn, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03365.x · Cited by 159
Regulation of NMDA-Receptor Synaptic Transmission by Wnt Signaling
Cerpa, W., Gambrill, A., Inestrosa, N. C., & Barria, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6311-10.2011 · Cited by 148
Calpain‐mediated degradation of p35 to p25 in postmortem human and rat brains
Taniguchi, S., Fujita, Y., Hayashi, S., Kakita, A., Takahashi, H., Murayama, S., Saido, T. C., Hisanaga, S., Iwatsubo, T., & Hasegawa, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02431-5 · Cited by 148
β-catenin is required for memory consolidation
Maguschak, K. A., & Ressler, K. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2198 · Cited by 145
Gómez Ravetti, M., Rosso, O. A., Berretta, R., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 140
Davis, E. K., Zou, Y., & Ghosh, A. (2008) · Neural Development · doi:10.1186/1749-8104-3-32 · Cited by 135
Wnts in action: from synapse formation to synaptic maintenance
Dickins, E. M., & Salinas, P. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00162 · Cited by 135
Wnt-5aoccludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
Cerpa, W. F., Farías, G. G., Godoy, J. A., Fuenzalida, M., Bonansco, C., & Inestrosa, N. C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-3 · Cited by 130
RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays
Koppelkamm, A., Vennemann, B., Lutz‐Bonengel, S., Fracasso, T., & Vennemann, M. (2011) · International Journal of Legal Medicine · doi:10.1007/s00414-011-0578-1 · Cited by 126
Weis, S., Llenos, I. C., Dulay, J. R., Elashoff, M. R., Martínez-Murillo, F., & Miller, C. L. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.06.001 · Cited by 118
Sahara, N., DeTure, M., Ren, Y., Ebrahim, A.-S., Kang, D., Knight, J., Volbracht, C., Pedersen, J. T., Dickson, D. W., Yen, S.-H., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121093 · Cited by 106
Association of GSK3B with Alzheimer disease and frontotemporal dementia
Schaffer, B. A. J., Bertram, L., Miller, B. L., Mullin, K., Weintraub, S., Johnson, N., Bigio, E. H., Mesulam, M., Wiedau-Pazos, M., Jackson, G. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1368 · Cited by 100
Canonical Wnt Signaling is Necessary for Object Recognition Memory Consolidation
Fortress, A. M., Schram, S. L., Tuscher, J. J., & Frick, K. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0659-13.2013 · Cited by 100
Stress‐induced hyperphosphorylation of tau in the mouse brain
Okawa, Y., Ishiguro, K., & Fujita, S. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03883-8 · Cited by 98
Wnt signaling: Role in LTP, neural networks and memory
Oliva, C. A., Vargas, J., & Inestrosa, N. C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.006 · Cited by 96
Yuan, Z., Agarwal-Mawal, A., & Paudel, H. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308298200 · Cited by 86
Baum, L., Hansen, L. A., Masliah, E., & Saitoh, T. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815006 · Cited by 80
Selection of Candidate Housekeeping Genes for Normalization in Human Postmortem Brain Samples
Penna, I., Vella, S., Gigoni, A., Russo, C., Cancedda, R., & Pagano, A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095461 · Cited by 79
Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
Kwok, J. B., Loy, C. T., Hamilton, G., Lau, E., Hallupp, M., Williams, J. H., Owen, M. J., Broe, G. A., Tang, N. L. S., LAM, L. C. W., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21476 · Cited by 77
Ghanevati, M., & Miller, C. A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:1:079 · Cited by 73
Wnt transmembrane signaling and long‐term spatial memory
Tabatadze, N., Tomas, C., McGonigal, R., Lin, B., Schook, A. C., & Routtenberg, A. (2011) · Hippocampus · doi:10.1002/hipo.20991 · Cited by 67
Rizzu, P., Joosse, M., Ravid, R., Hoogeveen, A., Kamphorst, W., van Swieten, J. C., Willemsen, R., & Heutink, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3075 · Cited by 66
Zhukareva, V. A., Sundarraj, S., Mann, D. M. A., Sjögren, M. J. C., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0668-8 · Cited by 54
Newmark, R. E., Schön, K., Ross, R. S., & Stern, C. E. (2013) · Hippocampus · doi:10.1002/hipo.22106 · Cited by 53
Mateo, I., Infante, J., Llorca, J., Rodríguez, E., Berciano, J., & Combarros, O. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091044 · Cited by 53
Alarcón, M. A., Medina, M. A., Hu, Q., Ávila, M. E., Bustos, B. I., Pérez‐Palma, E., Peralta, A. B., Salazar, P. L., Ugarte, G. D., Reyes, A. E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.004 · Cited by 53
Shruster, A., Eldar-Finkelman, H., Melamed, E., & Offen, D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07131.x · Cited by 46
Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains
van Eersel, J., Bi, M., Ke, Y. D., Hodges, J. R., Xuereb, J. H., Gregory, G. C., Halliday, G. M., Götz, J., Kril, J. J., & Ittner, L. M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0293-y · Cited by 40
Wnt-5a Is a Synaptogenic Factor with Neuroprotective Properties against Aβ Toxicity
Varela‐Nallar, L., Parodí, J., Farías, G. G., & Inestrosa, N. C. (2012) · Neurodegenerative Diseases · doi:10.1159/000333360 · Cited by 34
Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice
Wiedau‐Pazos, M., Wong, E., Solomon, E., Alarcón, M., & Geschwind, D. H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.015 · Cited by 25
Cited by
Lim, R. G., Quan, C., Reyes-Ortiz, A. M., Lutz, S. E., Kedaigle, A. J., Gipson, T. A., Wu, J., Vatine, G. D., Stocksdale, J., Casale, M. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.021 · Cited by 253
Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease
Arredondo, S. B., Valenzuela-Bezanilla, D., Mardones, M. D., & Varela‐Nallar, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00860 · Cited by 174
Smith, A. R., Smith, R. G., Pishva, E., Hannon, E., Roubroeks, J. A. Y., Burrage, J., Troakes, C., Al-Sarraj, S., Sloan, C., Mill, J., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0636-y · Cited by 118
Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer’s Disease
Folke, J., Pakkenberg, B., & Brudek, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1103-z · Cited by 123
Self-citationHow Wnt Signaling Builds the Brain: Bridging Development and Disease
Noelanders, R., & Vleminckx, K. (2017) · The Neuroscientist · doi:10.1177/1073858416667270 · Cited by 107
Metadata
- Authors
- Riise, J., Plath, N., Pakkenberg, B., & Parachikova, A.
- Affiliations
- University of Copenhagen (DK)
- Lundbeck (Denmark) (DK)
- Bispebjerg Hospital (DK)
- Corresponding author
- Riise, Jesper
- Venue
- Journal of Neural Transmission
- Published
- 2015-02-14
- Volume
- 122
- Issue
- 9
- Pages
- 1303-1318
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2022717467
- Cited by
- 66
- References
- 71
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 11 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 11 · 2016: 5
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, Wnt signaling, medial temporal lobe, hippocampus, entorhinal cortex, Wnt7b, β-catenin, GSK3β, β-catenin phosphorylation, tau hyperphosphorylation, tau aggregation, neurofibrillary tangles, cognitive impairment, synaptic dysfunction, gene expression changes
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Male, Middle Aged, Phosphorylation, RNA, Messenger, Immunoblotting, tau Proteins, Entorhinal Cortex, Wnt Signaling Pathway, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.